Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 260

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Liver fibrosis scores predict liver disease mortality in the United States population

Open access
Unalp‐Arida, Aynur, Ruhl, Constance E. · 2017 · Hepatology

Abstract

Fatty liver disease is common in the United States and worldwide due to changing lifestyles and can progress to fibrosis and cirrhosis contributing to premature death. We examined whether liver fibrosis scores were associated with increased overall and disease‐specific mortality in a United States population–based prospective survey with up to 23 years of linked‐mortality data. Data were analyzed from 14,841 viral hepatitis–negative adult participants in the third National Health and Nutrition Examination Survey, 1988‐1994. Liver fibrosis was predicted using the aspartate aminotransferase–to‐platelet ratio index (APRI), fibrosis‐4 (FIB‐4) score, nonalcoholic fatty liver disease fibrosis score (NFS), and Forns score. Participants were passively followed for mortality, identified by death certificate underlying or contributing causes, by linkage to National Death Index records through 2011. Hazard ratios (HR) for mortality were calculated using Cox proportional hazards regression to adjust for mortality risk factors. During follow‐up, cumulative mortality was 28.0% from all causes and 0.82% with liver disease, including primary liver cancer. Elevated liver disease mortality was found with an intermediate to high APRI (HR, 9.44; 95% confidence interval [CI], 5.02‐17.73), intermediate (HR, 3.15; 95% CI, 1.33‐7.44) or high (HR, 25.14; 95% CI, 8.38‐75.40) FIB‐4 score, high NFS (HR, 6.52; 95% CI, 2.30‐18.50), and intermediate (HR, 3.58; 95% CI, 1.78‐7.18) or high (HR, 63.13; 95% CI, 22.16‐179.78) Forns score. Overall mortality was also greater with higher fibrosis scores. Conclusion: In the United States population, higher liver fibrosis scores were associated with increased liver disease and overall mortality. Liver health management with common clinical measures of fibrosis risk stratification merits further investigation. (H epatology 2017;66:84–95).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.29113

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 260

Metadata

Authors
Unalp‐Arida, A., & Ruhl, C. E.
Venue
Hepatology
Published
2017-05-16
Volume
66
Issue
1
Pages
84-95
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2588592564
Cited by
260
References
47
FWCI
11.69
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver fibrosis scores predict liver disease mortality in the United States population. https://app.cochat.ai/papers/10.1002/hep.29113
The paper
Unalp‐Arida, A., & Ruhl, C. E. (2017). Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology. https://doi.org/10.1002/hep.29113

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.